← brief for 2026-09-25 · Slowing decline

Real-world Evidence for Improvements in Inflammation and Anemia Biomarkers After the Initiation of GLP-1RA in Patients Receiving Hemodialysis.

Article C Peer reviewed Observational

Key takeaways

This study looked at 2,468 people on dialysis who started a diabetes drug called a GLP-1 agonist. It compared them to a similar group that did not take the drug. The group taking the drug had lower signs of inflammation and better blood counts. This shows a link, but it is not proof that the drug caused the change.

Who did this work

Lama S · Chaudhuri S · Blankenship D · Ban AN · Usvyat L · Pecoits-Filho R · Hippen BE

Source

Article · PubMed, the drug frontier · 2026 Jul 17
https://pubmed.ncbi.nlm.nih.gov/42787930/